Lsv Associates, Llc - Net Worth and Insider Trading

Lsv Associates, Llc Net Worth

The estimated net worth of Lsv Associates, Llc is at least $6 Million dollars as of 2024-11-13. Lsv Associates, Llc is the 10% Owner of ALX Oncology Holdings Inc and owns about 4,526,963 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $6 Million. Details can be seen in Lsv Associates, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lsv Associates, Llc has not made any transactions after 2021-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lsv Associates, Llc

To

Lsv Associates, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lsv Associates, Llc owns 2 companies in total, including ALX Oncology Holdings Inc (ALXO) , and Disc Medicine Inc (IRON) .

Click here to see the complete history of Lsv Associates, Llc’s form 4 insider trades.

Insider Ownership Summary of Lsv Associates, Llc

Ticker Comapny Transaction Date Type of Owner
ALXO ALX Oncology Holdings Inc 2021-12-13 10 percent owner
IRON Disc Medicine Inc 2021-02-05 10 percent owner

Lsv Associates, Llc Latest Holdings Summary

Lsv Associates, Llc currently owns a total of 1 stock. Lsv Associates, Llc owns 4,526,963 shares of ALX Oncology Holdings Inc (ALXO) as of December 13, 2021, with a value of $6 Million.

Latest Holdings of Lsv Associates, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXO ALX Oncology Holdings Inc 2021-12-13 4,526,963 1.35 6,111,400

Holding Weightings of Lsv Associates, Llc


Lsv Associates, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Lsv Associates, Llc has made a total of 3 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in ALX Oncology Holdings Inc is the sale of 48,390 shares on December 13, 2021, which brought Lsv Associates, Llc around $1 Million.

Insider Trading History of Lsv Associates, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lsv Associates, Llc Trading Performance

GuruFocus tracks the stock performance after each of Lsv Associates, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lsv Associates, Llc is 38.74%. GuruFocus also compares Lsv Associates, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lsv Associates, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lsv Associates, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lsv Associates, Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 46.47 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 42.18 LIMIT LIMIT LIMIT LIMIT LIMIT

Lsv Associates, Llc Ownership Network

Ownership Network List of Lsv Associates, Llc

No Data

Ownership Network Relation of Lsv Associates, Llc

Insider Network Chart

Lsv Associates, Llc Owned Company Details

What does ALX Oncology Holdings Inc do?

Who are the key executives at ALX Oncology Holdings Inc?

Lsv Associates, Llc is the 10 percent owner of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include VP & Finance and CAO Shelly Pinto , Chief Medical Officer Sophia Randolph , and director & President and CEO Jaume Pons .

ALX Oncology Holdings Inc (ALXO) Insider Trades Summary

Over the past 18 months, Lsv Associates, Llc made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .

In summary, during the past 3 months, insiders sold 3,866 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 0 shares, with a net sale of 3,866 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 28,400 shares were bought by its insiders, resulting in a net sale of 150,921 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ALX Oncology Holdings Inc Insider Transactions

No Available Data

Lsv Associates, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Lsv Associates, Llc. You might contact Lsv Associates, Llc via mailing address: 2884 Sand Hill Road, Suite 121, Menlo Park Ca 94025.